Estimated read time: 4-5 minutes
If you’ve spent any time in psychedelic spaces, online or in person, you’ve probably noticed people talk about whether to microdose or macrodose like they’re two stops on the same road. Start small, work your way up, eventually you’re doing a “real” journey. Or the message that microdosing is a placebo, training wheels, or not worth it if you’re not taking a giant amount of mushrooms to blow yourself out of the universe. That framing isn’t just inaccurate, it’s actually quite unhelpful.
Microdosing and macrodosing aren’t a beginner and advanced version of the same thing. They’re different tools that answer different questions, operate on different timelines, and often fit into someone’s life in completely different ways. Knowing which one you actually need right now, not which one sounds more impressive, is usually the difference between an experience that changes something and one you just kind of had.
What a microdose is actually doing
A microdose is sub-perceptual, meaning you’re not tripping. You’re able to manage daily life tasks and responsibilities. There’s no dramatic shift in consciousness; rather a gentle opening, uplifting, or clearing of the normal fog and brain chaos that’s normally there.
What you’re doing is introducing a small, consistent signal to your nervous system over time, and that word “over time” matters more than people give it credit for. Although many people experience instant benefits, microdosing isn’t built for a single dramatic moment. It’s a longer-term, more subtle practice, and subtle doesn’t mean weak. In fact, as the research below shows, it may be one of the more quietly powerful tools available for mental health support.
The catch is that subtle doesn’t mean passive. A microdosing practice without intention, tracking, consistency, and integration is just taking something and hoping. The people who get the most out of it are the ones treating it like an actual practice, not a supplement they take and forget about.
What a macrodose is actually doing
A full journey is a different animal entirely. You’re not managing daily functioning, you’re stepping outside your ordinary state of consciousness for a defined period, usually with a specific question, block, or intention driving it. This is concentrated work. It tends to surface things quickly, sometimes things you didn’t know were there, and it requires real containment: preparation beforehand, support during, and integration after.
Neither one is “more serious” than the other. A macrodose isn’t the graduate-level version of a microdose. They’re built for different jobs, on different timelines, with different levels of support required.
The little-known benefits of microdosing for mental health
Most of the public conversation about microdosing focuses on creativity or productivity, but the more interesting story, especially from where I sit clinically, is what it may offer for actual mental health symptom relief. And it’s become one the most powerful modalities for myself and my therapy clients.
What the research is showing. One large self-report study following thousands of participants found that people who microdosed reported meaningfully lower depression and anxiety compared to non-microdosers, with improved mood tracked over the course of a month. To put the size of that effect in plain terms: the improvement in depression symptoms was in a medium range, comparable to or larger than the effect size typically reported for SSRIs in clinical trials. That’s a striking comparison for something often dismissed as too subtle to matter. It’s also, importantly, observational data from a non-clinical population rather than a randomized controlled trial, so it points toward something real without yet proving exactly how or why. Still, it’s a meaningful signal, and part of why more rigorous research in this area is now underway.
The SSRI and SNRI connection. Serotonergic antidepressants work partly by downregulating certain serotonin receptors over time, the same receptors psilocybin and LSD act on. In practice, this often means the effects of psychedelics, including microdoses, can feel blunted for people currently on these medications, sometimes substantially. Some people report that microdosing still offers subtle mood and cognitive benefits alongside their SSRI or SNRI. Others notice little to no effect at all. The honest answer is that this varies quite a bit person to person and isn’t fully predictable in advance.
Additionally, in my personal private practice, I’m seeing people come off their years-long regimens of antidepressants, benzos, alcohol, sleep meds, etc. simply by microdosing with intention and in a therapeutic container.
Where this becomes useful is in preparing for a future macrodose journey. Because a full journey’s effects can be significantly dampened by ongoing SSRI or SNRI use, some people work with their prescriber and a therapist to gradually taper off these medications ahead of planned journey work. Microdosing can be one part of that longer transition, offering nervous system support and continuity of care during a period when someone is stepping down from a medication they’ve relied on. This is not something to approach casually or alone. Tapering off any psychiatric medication needs to happen gradually and under the direct supervision of the prescribing provider, given the real risk of withdrawal effects and symptom return. Microdosing alongside that process is a support, not a replacement for medical guidance.
Why it integrates so easily alongside therapy. One of the most underrated things about microdosing, clinically, is how little it disrupts someone’s existing life or care. A macrodose journey requires setting aside a full day, a facilitator, and significant preparation. A microdosing practice fits inside an existing therapy relationship. The subtle shifts in mood, openness, and cognitive flexibility that people describe often create more workable material for a session, more access to emotions that were previously harder to reach, without requiring an altered state to get there. It’s less a separate intervention and more a quiet adjunct sitting underneath the work you’re already doing.
The accessibility piece nobody talks about enough
There’s another dimension when it comes to choosing whether to microdose or macrodose that rarely comes up in the online conversation: access. A guided macrodose journey requires a qualified facilitator, a safe container, travel in many cases, and a real financial and time investment. For a lot of people, especially those without a facilitator anywhere nearby, that’s simply not available right now, regardless of how ready they might feel.
Microdosing, by comparison, tends to be more financially accessible and doesn’t require geographic proximity to a facilitator or clinic. It can be built into an existing daily routine, with far lower logistical barriers. That doesn’t make it a consolation prize. For a lot of people, a sustained microdosing practice is genuinely the more appropriate tool, not just the more available one. Accessibility and appropriateness aren’t opposites; sometimes they point in the exact same direction.
So which one do you actually need
A few questions worth sitting with, honestly:
- Am I looking for support with something ongoing (mood, focus, day-to-day resilience), or am I trying to get unstuck from something specific?
- Do I have the containment and support in place for a full journey right now, including access to a qualified facilitator, or would a slower, lower-intensity practice serve me better first?
- Am I on any medications that would shape which path makes more sense, and have I actually talked that through with my prescriber?
- Am I drawn to one of these because it’s genuinely right for me, or because it’s the one I’ve seen more people talk about online?
That last question matters more than people give it credit for. A lot of what circulates about microdosing and macrodosing is shaped by what’s trending, not by what any individual person actually needs.
Where this becomes less theoretical
This is exactly the conversation I have with people in a consultation call, and it’s also the foundation of how my services are built. During our free consultation we’ll review your intentions, contraindications, and practical needs to help determine what route feels best for you.
Support that’s right for you: Microdose coaching and macrodose journeys aren’t a one-size-fits-all protocol; it’s a therapeutically-informed container designed to help you figure out what your nervous system and your specific situation are actually asking for, whether that’s dose, timing, medication considerations, or whether microdosing is even the right entry point compared to a guided journey.
Embodied Microdosing is a 3-month integrative psilocybin program that runs as both a group program and one-on-one, so there’s a version of it depending on whether you want the accountability and shared experience of a cohort or a more individualized pace with me directly.
Psilocybin Therapy or Mushroom Journeys offer fully supported and guided macrodose journeys for reaching deeper levels of healing, personal growth, and spiritual connection. Includes full preparation and integration support before and after the journey.
If you’ve been going back and forth on which path makes sense, that’s usually a sign it’s worth talking through rather than guessing at. A consultation call is a low-pressure place to actually sort that out.
Schedule a free consultation →
Learn more about Embodied Microdosing (group or individual) →
This post is educational and is not a substitute for individualized medical or clinical guidance. Any changes to prescribed medication should be made only in consultation with the prescribing provider.
Research Info/Links:
RAND 2026: Prevalence: ~10M U.S. adults microdosed in 2025; most cite health-related motivations.
Rootman 2022: Naturalistic (N=953): psilocybin microdosers showed greater mood and mental-health gains at 1 month vs. non-microdosers.
St. Pierre 2025: Daily self-assessment (N=1,435): higher wellbeing, productivity, creativity on dosing days. No control group.
